Skip to comments.New "Splinter Cell" Super-Immune Cells Created; Ready to Fight Cancer, AIDS
Posted on 04/29/2010 1:46:20 PM PDT by Ernest_at_the_Beach
To prevent these cells from growing and proliferating out of control (the whole reason for the cytokine system), the researchers encoded a cellular RNA switch that confers a new sensitivity to a specific drug (different riboswitches were used, including ones sensitive to the drugs tetracycline and theophylline). The T cells only produce their own cytokines when exposed to this drug.
The super-cells featured 24 percent more live cells, when cultured, than normal T cells. They also had a 50 percent reduced death rate.
killing cancer bump
T cells protect our bodies against attackers like bacteria, cancer, and the AIDS virus. Scientists at Stanford have found a way to not only target them to threats more effectively (past work), but to allow them to act independent of other immune cells (new work). (Source: Laplacian Files)
Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems
Forgive the Wikipedia link, Ribozyme.
Great articles. Thanks for the ping.
I did state it ....just didn’t use the FR mechanism...
· Discover · Nat Geographic · Texas AM Anthro News · Yahoo Anthro & Archaeo · Google ·
· The Archaeology Channel · Excerpt, or Link only? · cgk's list of ping lists ·
Thank you Ernest. I’ve been an investor in Dendreon for over 7 years. Today was the culmination of 15 years of research, trials and yes, unnecessary patient deaths caused by an FDA delay the first time it came up for approval. Today is the begining of a new way to treat cancer. Prosate cancer is only the first. Dendreon has a pipeline; this is no one-trick pony. And yes, i’d recommend buying some stock. This will be Amgn or Celgene within a few years.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.